Skip to main content
. 2021 Nov;10(11):4591–4600. doi: 10.21037/tcr-21-1128

Table 3. Multivariate analysis results of different populations based on the COX proportional hazards model.

Site of metastasis, n (%) Treatment OS CSS
HR (95% CI) P value HR (95% CI) P value
Bone, 59 (11.0) S or/and R + C
C 3.326 (1.168–9.468) 0.024 3.139 (1.100–8.961) 0.033
S or/and R 2.413 (0.929–6.268) 0.070 2.405 (0.912–6.339) 0.076
N 4.870 (1.823–13.011) 0.002 4.493 (1.647–12.256) 0.003
Liver, 130 (24.2) S or/and R + C
C 1.380 (0.757–2.514) 0.293 1.380 (0.749–2.545) 0.302
S or/and R 3.478 (1.581–7.649) 0.002 3.533 (1.598–7.810) 0.002
N 9.196 (4.649–18.190) 0.000 9.218 (4.612–18.425) 0.000
Lung, 191 (35.6) S or/and R + C
C 1.071 (0.586–1.957) 0.825 1.020 (0.542–1.918) 0.951
S or/and R 1.979 (1.398–3.631) 0.001 2.262 (1.384–3.696) 0.001
N 3.393 (2.221–5.185) 0.000 3.238 (2.078–5.044) 0.000
Multiple, 149 (27.7) S or/and R + C
C 1.092 (0.611–1.952) 0.766 1.109 (0.617–1.995) 0.729
S or/and R 3.391 (1.856–6.197) 0.000 3.490 (1.902–6.404) 0.000
N 4.702 (2.662–8.305) 0.000 4.649 (2.609–8.286) 0.000

OS, overall survival; CSS, cancer-specific survival; S, surgery; R, radiotherapy; C, chemotherapy; N, no treatment.